Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kowa Pharmaceuticals America Inc.

Division of Kowa Co. Ltd.
www.kowapharma.com

Latest From Kowa Pharmaceuticals America Inc.

UnitedHealth 2018 Formulary Updates Broaden Exclusions, Deter Copay Coupons

Insurer will begin excluding drugs when there are less expensive and clinically equivalent alternatives available and eliminate manufacturer coupons from the calculation of deductibles and out-of-pocket limits.

Pricing Strategies Market Access

Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements

Seeking to protect its competitive interests, Vascepa marketer asks the US International Trade Commission to investigate importation and sale of synthetically produced omega-3 products by 18 companies; complaint asserts the products at issue are unapproved new drugs that are illegally being marketed as dietary supplements.

Legal Issues Drug Approval Standards

Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements

Seeking to protect its competitive interests, Vascepa marketer asks the US International Trade Commission to investigate importation and sale of synthetically produced omega-3 products by 18 companies; complaint asserts the products at issue are unapproved new drugs that are illegally being marketed as dietary supplements.

Legal Issues Drug Approval Standards

Deals Shaping The Medical Industry, February 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Alias(es)
  • ProEthic Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Kowa Co. Ltd.
  • Senior Management
  • Benjamin Stakely, Pres. & CEO
    Joseph Barna, CFO
    Jeff Moore, VP, Sales
    Kenneth Riester, VP, Trade & Bus. Dev.
    Lou Mullikin, Chief Commercial Officer
    Craig Sponseller, MD, CMO
  • Contact Info
  • Kowa Pharmaceuticals America Inc.
    Phone: (334) 288-1288
    530 Industrial Park Blvd.
    Montgomery, AL 36117
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register